Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histamine H1 receptor, muscarinic acetylcholine receptors, and alpha-1 adrenergic receptors are three distinct families of G protein-coupled receptors that play pivotal roles in mediating neurotransmitter and hormone signaling across multiple organ systems. The Histamine H1 receptor is a principal mediator of allergy, inflammation, and wakefulness, targeted by antihistamine drugs that act as antagonists or inverse agonists[1][7][9]. Muscarinic acetylcholine receptors regulate parasympathetic nervous system functions, including smooth muscle contraction, glandular secretion, heart rate, and cognition. Alpha-1 adrenergic receptors respond to catecholamines (primarily norepinephrine) to modulate vascular tone, blood pressure, cardiac hypertrophy, and smooth muscle contraction[2][8]. Dysregulation or pharmacological modification of these receptors contributes to the treatment of allergic disease, hypertension, benign prostatic hyperplasia, heart failure, asthma, and a range of neuropsychiatric conditions[1][2][4][8]. While each is a singular, major drug target, grouping them together is nonstandard and should be revised for precise pharmacological or biological inquiries.
H1R: Antagonism or inverse agonism blocks histamine binding, preventing allergic and inflammatory responses and regulating sleep-wake cycle; Muscarinic: Antagonists block acetylcholine signaling to reduce involuntary muscle contraction and secretions; agonists stimulate parasympathetic activity; Alpha-1 adrenergic: Antagonists prevent noradrenaline or adrenaline binding, causing vasodilation and lowering blood pressure; agonists cause vasoconstriction
16 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine H1, Muscarinic, and Alpha-1 Adrenergic receptors (H1R, mAChR, α1-AR).